☆ 4.8 Article

48 weeks of high dose (10 mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV/HDV co-infection

JOURNAL OF HEPATOLOGY (2020)

Journal

JOURNAL OF HEPATOLOGY

Volume 73, Issue -, Pages S52-S53

Publisher

Elsevier BV

DOI: 10.1016/s0168-8278(20)30651-6

Keywords

-

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.